Astellas Pharma Europe, the European subsidiary of Tokyo-based Astellas Pharma Inc, one of the world's top 20 pharmaceutical companies, can announce details of an Astellas Changing Tomorrow Charity Award for the International Foundation for Dermatology. The Astellas Changing Tomorrow Charity Awards complement the company's existing ongoing Corpo
Biotel Inc. announced results for its first quarter ended September 30, 2009 with net earnings of $128,000, or $0.04 per diluted share, on revenues of $3,263,000.
Nov. 20TROY Although the merger between St. Peter's, Samaritan and Seton Health's St. Mary's hospitals is still being negotiated, two of the hospitals took a step on Thursday to consolidate their birthing services.
Boston Scientific Corporation today announced that it has received 510 clearance from the U.S. Food and Drug Administration and CE Mark approval to market its WallFlex Fully Covered Esophageal Stent for the treatment of malignant esophageal strictures caused by tumors in patients with resectable or non-resectable esophageal cancer.
Miami, FLA. This morning, Dragon Capital Group has announced that its financial results for the third quarter ended September 30, 2009, which included record revenues of $41.1 Million for first nine months of 2009, an increase of 21.87% compared to $33.7 Million for first nine months of 2008.
Following two years of steady corporate growth since its founding in 2007, BridgeHealth Medical, Inc., the nation's premier provider of medical travel services to high quality surgical centers of excellence at significantly lower prices, announced reaching a major benchmark: Over 1,000,000 lives under management by Third Party Administrators, emplo
Nov. 20The city is aiming to cut its health care costs by shifting retirees into less expensive health insurance plans. The decision, tentative for the past year and a half as Mayor Michael Tucker worked to gain consent of the city's five employee unions, is final now, Tucker said this week.
Date: Friday, November 20, 2009. Contact: Jim Manley, 224-2939. PUBLIC INTEREST GROUPS VOICE SUPPORT FOR SENATE HEALTH INSURANCE PROPOSAL, CONTINUING MOMENTUM FOR REFORM. Washington, DC - Numerous public interest groups have released statements in support of the Senate health insurance reform legislation, The Patient Protection and Affordable Care
Excerpts from recent editorials in newspapers in the United States and abroad: Nov. 15. San Antonio Express-News, on the swine flu vaccine: Health and Human Services Secretary Kathleen Sebelius has a consoling message for everyone who has tried unsuccessfully to get the H1N1 vaccine: Don't worry - more vaccine is on the way.
preliminary opinion was announced in a press release issued last month. Antigenics Inc. today announced that the Committee for Medicinal Products for Human Use, the scientific committee of the European Medicines Agency, has formally adopted a negative opinion on the marketing authorization application for Oncophage as a treatment in earlier-stage,
A diverse group of health care and consumer organizations released five policy recommendations this week that are designed to promote better medication adherence and improved health outcomes for patients.
Revatio is the Only Treatment in Its Class with Both Oral and Intravenous Formulations. Pfizer announced today that the U.S. Food and Drug Administration has approved Revatio Injection, an intravenous formulation of Revatio. Revatio is indicated for the treatment of adult patients with pulmonary arterial hypertension to improve exercise ability and
CombinatoRx, Incorporated and Neuromed Pharmaceuticals Inc., a privately-held biopharmaceutical company, today announced that the U.S. Food and Drug Administration has issued Neuromed a letter extending its review of the New Drug Application for the product candidate Exalgo extended-release tablets by three months.
Hexvix new drug application will be discussed in Oncologic Drugs Advisory Committee meeting scheduled for 17th December 2009. Photocure submitted the NDA on 30 June 2009 and achieved a priority review scheduled to be completed by 30 December 2009.
The FDA was set to decide this week whether to approve Rituxan for chronic lymphocytic leukemia - a common form of adult leukemia - but a complete response letter the agency issued has effectively delayed the decision..
Five Star Quality Care, Inc. announced its financial results for the quarter and nine months ended September 30, 2009. Net income for the third quarter of 2009 was $4.1 million compared to a net loss of $2.3 million for the same period last year.
Guidance for Industry on Changes to Approved New Animal Drug ApplicationsNew Animal Drug Applications Versus Category II Supplemental New Animal Drug Applications; Availability. SUMMARY: The Food and Drug Administration is announcing the availability of a guidance for industry #191 entitled "Changes to Approved NADAsNew NADAs vs.
New Haven, Conn. With over 1,000 students, almost 2,000 faculty and a budget approaching $1 billion, the enterprise over which Alpern presides is by far the largest of the University's graduate programs. The Yale Bulletin & Calendar recently met with Alpern, who reflected on his first term at Yale and shared his vision for the future.
GE Healthcare, a unit of General Electric Company, announces the global launch of the first biomolecular imaging systems developed as part of its strategic alliance with FUJIFILM.
Data Presented at International Melanoma Conference in Berlin. Results Follow Decision by Company to Continue Phase 3 AGENDA Trial for Overall Survival.
General Dynamics Information Technology, a business unit of General Dynamics, today announced that its managing director of healthcare informatics, Joe Nichols, M.D., has received a Workgroup for Electronic Data Interchange's 2009 Award of Merit.
According to Millennium Research Group, the global authority on medical technology market intelligence, the atrial fibrillation device market will grow by almost 10% through 2013 in the US, Europe, and Japan.
Medicare Program: Changes to the Hospital Outpatient Prospective Payment System and CY 2010 Payment Rates; Changes to the Ambulatory Surgical Center Payment System and CY 2010 Payment Rates.
Health Care REIT, Inc. announced operating results for the company's third quarter ended September 30, 2009. "In the face of the significant challenges of 2009, we successfully disposed of non-core assets and will have completed over $700 million of development projects. "At the same time, we strengthened our balance sheet this year.
